$0.00010
At close: May 15, 10:38 AM EDT
Comments
Loading...
Paradigm Medical Indus Analyst Ratings and Price Targets | OTC:PDMI | Benzinga
Paradigm Medical Indus Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Paradigm Medical Indus Corp from these most-recent analyst ratings.
Analyst Ratings for Paradigm Medical Indus
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Paradigm Medical Indus (PDMI) stock?
There is no price target for Paradigm Medical Indus
What is the most recent analyst rating for Paradigm Medical Indus (PDMI)?
There is no analyst for Paradigm Medical Indus
When was the last upgrade for Paradigm Medical Indus (PDMI)?
There is no last upgrade for Paradigm Medical Indus
When was the last downgrade for Paradigm Medical Indus (PDMI)?
There is no last downgrade for Paradigm Medical Indus.
When is the next analyst rating going to be posted or updated for Paradigm Medical Indus (PDMI)?
There is no next analyst rating for Paradigm Medical Indus.
Is the Analyst Rating Paradigm Medical Indus (PDMI) correct?
There is no next analyst rating for Paradigm Medical Indus.
Browse analyst ratings and price targets on all stocks.
